Phase III study of the value of thalidomide added to melphalan plus prednisone in elderly patients with newly diagnosed multiple myeloma: the HOVON 49 Study.

P. Wijermans; M. Schaafsma; F. Termorshuizen; R. van Ammerlaan; S. Wittebol; H. Sinnige; S Zweegman; M. van Marwijk-Kooy; R. van der Griend; H.M. Lokhorst; P. Sonneveld

Phase III study of the value of thalidomide added to melphalan plus prednisone in elderly patients with newly diagnosed multiple myeloma: the HOVON 49 Study.

Translated title of the contribution: Phase III study of the value of thalidomide added to melphalan plus prednisone in elderly patients with newly diagnosed multiple myeloma: the HOVON 49 Study.

P. Wijermans
, M. Schaafsma
, F. Termorshuizen
, R. van Ammerlaan
, S. Wittebol
, H. Sinnige
, S Zweegman
, M. van Marwijk-Kooy
, R. van der Griend
, H.M. Lokhorst
, P. Sonneveld

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Phase III study of the value of thalidomide added to melphalan plus prednisone in elderly patients with newly diagnosed multiple myeloma: the HOVON 49 Study.
Original language	Undefined/Unknown
Pages (from-to)	3160-3166
Number of pages	7
Journal	Journal of Clinical Oncology
Volume	28
Issue number	19
Publication status	Published - 2010

Cite this

Wijermans, P., Schaafsma, M., Termorshuizen, F., van Ammerlaan, R., Wittebol, S., Sinnige, H., Zweegman, S., van Marwijk-Kooy, M., van der Griend, R., Lokhorst, H. M., & Sonneveld, P. (2010). Phase III study of the value of thalidomide added to melphalan plus prednisone in elderly patients with newly diagnosed multiple myeloma: the HOVON 49 Study. Journal of Clinical Oncology, 28(19), 3160-3166.

@article{873d6c45379e4f83bf9b3915fba49451,

title = "Phase III study of the value of thalidomide added to melphalan plus prednisone in elderly patients with newly diagnosed multiple myeloma: the HOVON 49 Study.",

author = "P. Wijermans and M. Schaafsma and F. Termorshuizen and \{van Ammerlaan\}, R. and S. Wittebol and H. Sinnige and S Zweegman and \{van Marwijk-Kooy\}, M. and \{van der Griend\}, R. and H.M. Lokhorst and P. Sonneveld",

year = "2010",

language = "Undefined/Unknown",

volume = "28",

pages = "3160--3166",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams \& Wilkins",

number = "19",

}

Wijermans, P, Schaafsma, M, Termorshuizen, F, van Ammerlaan, R, Wittebol, S, Sinnige, H, Zweegman, S, van Marwijk-Kooy, M, van der Griend, R, Lokhorst, HM & Sonneveld, P 2010, 'Phase III study of the value of thalidomide added to melphalan plus prednisone in elderly patients with newly diagnosed multiple myeloma: the HOVON 49 Study.', Journal of Clinical Oncology, vol. 28, no. 19, pp. 3160-3166.

TY - JOUR

T1 - Phase III study of the value of thalidomide added to melphalan plus prednisone in elderly patients with newly diagnosed multiple myeloma: the HOVON 49 Study.

AU - Wijermans, P.

AU - Schaafsma, M.

AU - Termorshuizen, F.

AU - van Ammerlaan, R.

AU - Wittebol, S.

AU - Sinnige, H.

AU - Zweegman, S

AU - van Marwijk-Kooy, M.

AU - van der Griend, R.

AU - Lokhorst, H.M.

AU - Sonneveld, P.

PY - 2010

Y1 - 2010

M3 - Article

SN - 0732-183X

VL - 28

SP - 3160

EP - 3166

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 19

ER -